Free Trial

Sinopharm Group (SHTDF) Short Interest Ratio & Short Volume

Sinopharm Group logo
$2.49 0.00 (0.00%)
As of 01/29/2025

Sinopharm Group Short Interest Data

Sinopharm Group (SHTDF) has a short interest of 4.19 million shares. This marks a -47.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 3,326 shares to cover all short positions.

Current Short Interest
4,186,900 shares
Previous Short Interest
7,957,000 shares
Change Vs. Previous Month
-47.38%
Dollar Volume Sold Short
$10.43 million
Short Interest Ratio
0.0 Days to Cover
Last Record Date
January 15, 2025
Today's Trading Volume
81 shares
Average Trading Volume
3,326 shares
Today's Volume Vs. Average
2%
Short Selling Sinopharm Group?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sinopharm Group and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SHTDF Short Interest Over Time

SHTDF Days to Cover Over Time

SHTDF Percentage of Float Shorted Over Time

Sinopharm Group Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/20254,186,900 shares $10.43 million -47.4%N/A0 $2.49
12/31/20247,957,000 shares $19.81 million +3.3%N/A437.2 $2.49
12/15/20247,701,800 shares $19.64 million +10.8%N/A12836.3 $2.55
11/30/20246,950,500 shares $17.52 million +13.6%N/A69505 $2.52
11/15/20246,119,300 shares $16.21 million -14.2%N/A20397.7 $2.65
10/31/20247,133,100 shares $18.44 million +140.0%N/A23777 $2.59
10/15/20242,972,500 shares $5.86 million -9.6%N/A376.3 $1.97
9/30/20243,289,200 shares $6.48 million +13.7%N/A0 $1.97
9/15/20242,893,200 shares $5.70 million +0.8%N/A28932 $1.97
8/31/20242,870,400 shares $5.91 million +60.5%N/A7176 $2.06
8/15/20241,788,000 shares $4.18 million -16.1%N/A436.1 $2.34
7/31/20242,131,000 shares $5.75 million -32.7%N/A444 $2.70
7/15/20243,165,300 shares $8.55 million +3.3%N/A234.5 $2.70
6/30/20243,065,000 shares $8.28 million -46.7%N/A10216.7 $2.70
6/15/20245,747,600 shares $15.52 million +7.7%N/A0 $2.70
5/31/20245,338,400 shares $14.41 million +7.8%N/A206.9 $2.70
5/15/20244,952,400 shares $14.56 million -24.2%N/A2913.2 $2.94
4/30/20246,534,900 shares $17.25 million +351.2%N/A9335.6 $2.64
4/15/20241,448,400 shares $3.56 million -37.3%N/A3621 $2.46
3/31/20242,310,200 shares $6.03 million +2.7%N/A11551 $2.61
3/15/20242,250,600 shares $6.21 million -9.0%N/A4501.2 $2.76
2/29/20242,473,400 shares $7.17 million +4.5%N/A916.1 $2.90
2/15/20242,366,100 shares $6.39 million +76.0%N/A4732.2 $2.70
1/15/20241,545,300 shares $4.11 million -69.1%N/A2575.5 $2.66
12/31/20234,998,100 shares $12.45 million +40.6%N/A1212 $2.49
12/15/20233,553,900 shares $8.86 million +52.1%N/A623.5 $2.49
11/30/20232,336,600 shares $5.85 million -4.2%N/A3338 $2.50
11/15/20232,438,900 shares $6.08 million +62.0%N/A554.3 $2.49
10/31/20231,505,300 shares $3.59 million -6.6%N/A91.8 $2.39
10/15/20231,611,900 shares $4.48 million +3.1%N/A2302.7 $2.78
9/30/20231,563,000 shares $4.57 million -25.8%N/A3126 $2.92
9/15/20232,106,800 shares $5.77 million +53.9%N/A10534 $2.74
8/31/20231,369,400 shares $3.86 million +22.5%N/A3155.4 $2.82
8/15/20231,117,600 shares $2.92 million -9.6%N/A2794 $2.61
7/31/20231,236,000 shares $3.79 million +49.8%N/A1236 $3.07
7/15/2023825,200 shares $2.54 million -2.5%N/A191.9 $3.07
6/30/2023846,500 shares $2.51 million -6.2%N/A445.5 $2.96
6/15/2023902,400 shares $2.96 million +2.6%N/A3008 $3.28
5/31/2023880,000 shares $2.97 million -5.0%N/A977.8 $3.37
5/15/2023926,600 shares $3.22 million -4.8%N/A1029.6 $3.48
Is this the pin that pops the bubble? (Ad)

CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia… In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers. Go here now before it’s too late to find out why Nvidia shares are slumping so hard.

4/30/2023973,100 shares $3.53 million -7.3%N/A748.5 $3.63
4/15/20231,050,000 shares $3.20 million -36.1%N/A10500 $3.05
3/31/20231,642,200 shares $4.86 million -45.4%N/A161 $2.96
3/15/20233,006,800 shares $7.94 million -23.2%N/A1002.3 $2.64
2/28/20233,912,700 shares $10.76 million +9.8%N/A3912.7 $2.75
2/15/20233,564,200 shares $9.73 million -4.5%N/A43.5 $2.73
1/31/20233,732,900 shares $9.26 million +13.4%N/A296.3 $2.48
1/15/20233,292,900 shares $8.23 million -1.4%N/A38.4 $2.50
12/30/20223,340,600 shares $8.45 million +6.4%N/A1237.3 $2.53
12/15/20223,139,900 shares $8.39 million -0.9%N/A981.2 $2.67
11/30/20223,167,000 shares $6.75 million +25.9%N/A10556.7 $2.13
11/15/20222,516,100 shares $5.71 million -12.5%N/A83 $2.27
10/31/20222,874,600 shares $5.29 million -21.5%N/A373.3 $1.84
10/15/20223,663,100 shares $7.33 million -21.6%N/A6105.2 $2.00
9/30/20224,670,900 shares $9.01 million +6.6%N/A1167.7 $1.93
9/15/20224,382,200 shares $9.25 million -1.8%N/A706.8 $2.11
8/31/20224,464,500 shares $9.78 million -16.1%N/A14881.7 $2.19
8/15/20225,319,200 shares $12.13 million +11.7%N/A214.5 $2.28
7/31/20224,760,400 shares $11.23 million +0.4%N/A9520.8 $2.36
7/15/20224,739,700 shares $11.08 million -9.9%N/A23698.5 $2.34
6/30/20225,262,500 shares $12.52 million +6.6%N/A13156.3 $2.38
6/15/20224,935,800 shares $11.35 million -8.0%N/A2903.4 $2.30
5/31/20225,363,500 shares $12.60 million +2.5%N/A59.7 $2.35
5/15/20225,235,300 shares $11.62 million +15.4%N/A5235.3 $2.22
4/30/20224,537,600 shares $10.71 million -3.0%N/A1972.9 $2.36
4/15/20224,677,600 shares $10.15 million +3.1%N/A1559.2 $2.17
3/31/20224,536,900 shares $10.53 million +19.2%N/A1620.3 $2.32
3/15/20223,806,800 shares $8.20 million -9.8%N/A174.6 $2.16
2/28/20224,219,600 shares $9.89 million +1.7%N/A981.3 $2.35
2/15/20224,150,600 shares $10.09 million +8.9%N/A4150.6 $2.43
1/31/20223,810,200 shares $8.80 million +5.6%N/A320.2 $2.31
1/15/20223,606,700 shares $8.48 million -40.6%N/A751.4 $2.35
12/31/20216,075,100 shares $13.73 million -8.8%N/A601.5 $2.26
12/15/20216,658,900 shares $14.38 million -7.9%N/A164.8 $2.16
11/30/20217,227,200 shares $15.37 million -8.4%N/A1078.7 $2.13
11/15/20217,893,600 shares $18.08 million +2.1%N/A249 $2.29
10/29/20217,734,600 shares $18.18 million +3.0%N/A1045.2 $2.35
10/15/20217,507,200 shares $19.86 million +2.2%N/A6824.7 $2.65
9/30/20217,349,100 shares $19.14 million +15.7%N/A5249.4 $2.61
9/15/20216,351,900 shares $16.71 million No ChangeN/A593.6 $2.63
8/31/20216,352,100 shares $15.78 million +23.4%N/A542.9 $2.49
8/13/20215,149,500 shares $14.12 million -13.7%N/A432.7 $2.74
7/30/20215,965,200 shares $15.81 million -19.0%N/A727.5 $2.65
7/15/20217,362,100 shares $20.76 million -5.6%N/A701.2 $2.82
6/30/20217,796,000 shares $22.69 million +31.4%N/A4103.2 $2.91
6/15/20215,931,800 shares $19.87 million +33.8%N/A1603.2 $3.35
5/28/20214,432,200 shares $15.16 million +29.9%N/A2110.6 $3.42
5/14/20213,412,100 shares $10.75 million +2.0%N/A180.5 $3.15
4/30/20213,345,800 shares $10.17 million -36.7%N/A760.4 $3.04
4/15/20215,288,400 shares $13.70 million -8.6%N/A459.9 $2.59
Is this the pin that pops the bubble? (Ad)

CEO Jensen Huang does not want you knowing this dirty little secret about Nvidia… In fact, any day now we’re expecting a cease and desist from Nvidia’s lawyers. Go here now before it’s too late to find out why Nvidia shares are slumping so hard.

3/31/20215,787,300 shares $14.01 million -3.2%N/A964.6 $2.42
3/15/20215,977,300 shares $13.45 million -15.0%N/A1707.8 $2.25
2/26/20217,032,600 shares $16.17 million -14.6%N/A781.4 $2.30
2/12/20218,229,700 shares $20.37 million +4.8%N/A642.9 $2.48
1/29/20217,849,700 shares $19.39 million +3.3%N/A564.7 $2.47
1/15/20215,426,800 shares $12.89 million -9.2%N/A91.4 $2.38
12/31/20206,916,000 shares $16.39 million +27.4%N/A536.1 $2.37
12/15/20205,426,800 shares $13.32 million -9.2%N/A91.4 $2.46
11/30/20205,976,600 shares $15.54 million +6.7%N/A235.3 $2.60
11/15/20205,600,400 shares $13.38 million +48.8%N/A746.7 $2.39
10/30/20203,763,600 shares $8.88 million -28.2%N/A388 $2.36
10/15/20205,244,800 shares $11.54 million -0.4%N/A749.3 $2.20
9/30/20205,263,100 shares $11.05 million -2.8%N/A649.8 $2.10
9/15/20205,416,200 shares $13.41 million -3.3%N/A260.4 $2.48
8/31/20205,600,300 shares $13.69 million +8.2%N/A666.7 $2.45
8/14/20205,173,800 shares $12.78 million +1.4%N/A623.3 $2.47
7/31/20205,104,800 shares $12.51 million +7.4%N/A195.6 $2.45
7/15/20204,751,300 shares $11.88 million +2.7%N/A126.4 $2.50
6/30/20204,626,800 shares $11.89 million +96.0%N/A690.6 $2.57
6/15/20202,360,300 shares $5.90 million +8.3%N/A245.9 $2.50
5/29/20202,179,100 shares $5.03 million +0.2%N/A1281.8 $2.31
5/15/20202,174,800 shares $5.74 million +0.5%N/A1359.3 $2.64
4/30/20202,164,900 shares $5.69 million -0.5%N/A1665.3 $2.63
4/15/20202,176,400 shares $5.25 million -42.8%N/A444.2 $2.41
3/31/20203,804,700 shares $9.85 million -26.0%N/A1811.8 $2.59
3/13/20205,143,600 shares $12.24 million +29.4%N/A2857.6 $2.38
2/28/20203,974,400 shares $8.19 million +0.5%N/A567.8 $2.06
2/14/20203,953,000 shares $9.61 million +4.9%N/A0 $2.43
1/31/20203,766,900 shares $11.79 million +56.4%N/A1982.6 $3.13

SHTDF Short Interest - Frequently Asked Questions

What is Sinopharm Group's current short interest?

Short interest is the volume of Sinopharm Group shares that have been sold short but have not yet been covered or closed out. As of January 15th, investors have sold 4,186,900 shares of SHTDF short. Learn More on Sinopharm Group's current short interest.

Is Sinopharm Group's short interest increasing or decreasing?

Sinopharm Group saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 4,186,900 shares, a decline of 47.4% from the previous total of 7,957,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Sinopharm Group's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "personal services" compare to Sinopharm Group: Roche Holding AG (0.05%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short Sinopharm Group stock?

Short selling SHTDF is an investing strategy that aims to generate trading profit from Sinopharm Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sinopharm Group?

A short squeeze for Sinopharm Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SHTDF, which in turn drives the price of the stock up even further.

How often is Sinopharm Group's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SHTDF, twice per month. The most recent reporting period available is January, 15 2025.




This page (OTCMKTS:SHTDF) was last updated on 1/31/2025 by MarketBeat.com Staff
From Our Partners